Cost of new drugs could rise under CETA, but it’s hard to predict by how much

Cost of new drugs could rise under CETA, but it’s hard to predict by how much

When the Canada-EU trade deal was under negotiation, studies forecast billion-dollar price increases for Canada’s health care system when brand-name drug patents are extended. Now the government won’t project what the actual cost might be...

Close